MediQuest Therapeutics

Controlling Inflammation and Infection Topically

News

Press Releases

Patent Awarded to MediQuest Therapeutics - Company developing microemulsion delivery technology

6/22/2010

Raynaud's Disease/Vascana Confirmatory Clinical Study Completes Patient Screening

6/14/2010

FDA Grants Priority Review for MediQuest's Drug Application to treat Raynaud's Disease

6/25/08

MediQuest Therapeutics Submits Drug Application to FDA to treat Raynaud's Disease

4/28/08

MediQuest Hires Pharmaceutical Industry Veteran as Executive VP and Chief Clinical Officer

1/7/08

MediQuest Hires Pharmaceutical Industry Veteran as Senior VP of Sales

7/2/07

MediQuest Concludes Confirmatory Phase III Study of Raynaud's Therapy

6/25/07

MQX-503 Findings to be Presented at International Scleroderma Conference

5/17/07

MediQuest Therapeutics to Present Company Overview at BIO 2007 Business Forum

5/3/07

MediQuest Therapeutics Invited to Present at Invest Northwest Conference

3/19/07

MediQuest Hires Pharmaceutical Industry Veteran as VP, Clinical Development

2/7/07

MediQuest hires former CFO for Roche Consumer Health as new Chief Financial Officer

11/29/06

MQX-503 Phase IIIa clinical trial results hold promise for millions suffering from Raynaud's Disease

11/13/06

MediQuest Therapeutics, Inc. Announces Addition to Management Team

10/16/06

Dr. Jeff Gregory Joins MediQuest Therapeutics, Inc.'s Management Team

7/13/06

MediQuest Therapeutics Raises $16.0 Million In Series A Financing

6/15/06

MediQuest Therapeutics Receives Special Protocol Assessment from the U.S. FDA

1/10/06

MediQuest Therapeutics, Inc. Enrolls Patients in its Phase IIB Clinical Study for the Treatment of Onychomycosis (Toenail Fungus)

1/4/06

MediQuest Therapeutics, Inc. Completes Phase IIIA Clinical Trials for Raynaud's Phenomenon

12/8/05

Patent Issued to MediQuest Therapeutics, Inc. for its Compounds Targeting Inflammation and Undesirable Cell Proliferation

11/14/05

MediQuest Panel Test Demonstrates Underarm Hair Growth Control

2/21/05

MediQuest Therapeutics Purchases Assets of IntegriDerm

2/9/04

MediQuest Therapeutics Purchases Assets of Taktix

7/14/03

MediQuest Therapeutics Receives NIH Funding

6/2/03

Tyler Ellison Joins MediQuest Therapeutics

2/5/03

Media Coverage

Mediquest asks for FDA approval of drug

Seattle Times 4/28/08

Emerging Drug Developer: MediQuest Therapeutics

Fierce Biotech 11/8/2007

MediQuest on the cusp of marketing first product

Seattle PI 8/18/2007

MediQuest looks to attract investors

Daily Herald 3/21/2007

Bothell firm in the money

Daily Herald 6/16/06

Calling their own shots

Daily Herald 1/30/06